Improving cancer diagnosis to better identify aggressive cases
Analytic diagnosis methods for disease ruling
This study is working on better ways to diagnose prostate cancer so that doctors can tell the difference between serious and less serious cases, helping patients get the right treatment without unnecessary tests.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10882230 on NIH RePORTER |
What this research studies
This research focuses on enhancing the methods used to diagnose cancer, particularly prostate cancer, by developing new analytic frameworks that help distinguish between aggressive and low-risk cases. The project aims to create a performance metric that directly relates to clinical utility, which will guide medical decision-making. By employing advanced statistical and computational techniques, the research seeks to formulate diagnostic rules that can accurately assess cancer risk while minimizing unnecessary procedures like biopsies. Patients will benefit from more precise diagnoses that can lead to better treatment decisions.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at risk for prostate cancer, particularly those with intermediate to high-risk factors.
Not a fit: Patients with low-risk prostate cancer who are not candidates for aggressive treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate cancer diagnoses, reducing unnecessary treatments and improving patient outcomes.
How similar studies have performed: Previous research has shown promise in developing analytic methods for cancer diagnosis, indicating that this approach could yield significant advancements.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Huang, Yijian — Emory University
- Study coordinator: Huang, Yijian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.